Channel Therapeutics Quote - CHRO

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.575034

Bid

Offer

Volume

44,687

0.5099 Day's Range 0.665

0.45 52 Week Range 6.00

Market Cap

3.466M

Previous Close

0.6192

Open

0.649

Last Trade

299

0.575034

Last Trade Time

04:33:49

Financial Volume

US$ 26,727

VWAP

0.598103

Average Volume (3m)

135,431

Shares Outstanding

6,028,011

Dividend Yield

PE Ratio

-0.51

Earnings Per Share (EPS)

-1.22

Revenue

Net Profit

-7.38M

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

chromocell.com

Headquarters

Wilmington, Delaware, USA

Founded

Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Channel Therapeutics was US$0.62. Over the last year, Channel Therapeutics shares have traded in a share price range of US$ 0.45 to US$ 6.00.

Channel Therapeutics currently has 6,028,011 shares in issue. The market capitalisation of Channel Therapeutics is US$3.73 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -0.51.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.064966	-10.1509375	0.64	0.69	0.45	33764	0.60432968	CS
4	-0.214966	-27.2108860759	0.79	0.9327	0.45	98975	0.6964337	CS
12	-0.290966	-33.5988452656	0.866	1.11	0.45	135431	0.79789284	CS
26	-1.164966	-66.9520689655	1.74	1.92	0.45	76285	0.8535967	CS
52	-5.424966	-90.4161	6	6	0.45	59841	1.16674924	CS
156	-5.424966	-90.4161	6	6	0.45	59841	1.16674924	CS
260	-5.424966	-90.4161	6	6	0.45	59841	1.16674924	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BIGYYieldmax Target 12 Big 50 Option Income ETF	49.955 (176.15%)	13.81k
SNOYYieldmax Snow Option Income Strategy ETF	US$ 22.0713 (25.69%)	45.72k
HYLNHyliion Holdings Corp	US$ 3.585 (23.20%)	2.33M
MGLDMarygold Companies Inc	US$ 1.45 (20.83%)	13k
ETHTProshares Ultra Ether ETF	US$ 24.0801 (17.64%)	692.65k
CATXPerspective Therapeutics Inc	US$ 3.4475 (-44.12%)	7.24M
ETQT Rex 2X Inverse Ether Daily Target ETF	US$ 11.58 (-17.96%)	5.76k
ETHDProshares Ultrashort Ether ETF	US$ 26.05 (-17.14%)	98.92k
ROLRHigh Roller Technologies Inc	US$ 6.0501 (-16.55%)	18.8k
EFSH1847 Holdings LLC	US$ 0.345 (-12.55%)	2.23M
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 0.816399 (0.44%)	973.9M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 28.237 (4.08%)	64.51M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.1001 (1.31%)	53.19M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6.1005 (-1.29%)	48.42M
ETHU2x Ether ETF	US$ 8.675 (17.39%)	28.76M